Submit Deal

NEWLIMIT

Summary

NewLimit is a biotechnology company working to extend human healthspan by developing epigenetic reprogramming therapies.

Market Context

Deals Overview

Total Deals0

Valued Deals0

Total Valuevalue n/a

Avg. Deal Sizevalue n/a

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

No dealmakers exist